Precipio, Inc. (PRPO)
Healthcare • Diagnostics & Research
StockNasdaqCMUnited StatesUS74019L6020
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Precipio, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:36. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 13 Nov 2023 16:00 | -1.40 | -1.04 | +25.7% | Beat |
| 11 Aug 2023 16:00 | -2.00 | -1.80 | +10.0% | Beat |
| 12 May 2023 16:00 | -2.60 | -2.60 | 0.0% | In line |
| 30 Mar 2023 16:00 | -2.80 | -2.00 | +28.6% | Beat |
| 10 Nov 2022 16:00 | -0.80 | -2.80 | -250.0% | Miss |
| 11 Aug 2022 16:00 | -1.00 | -1.80 | -80.0% | Miss |
| 11 May 2022 16:00 | -1.00 | -4.00 | -300.0% | Miss |
| 30 Mar 2022 17:00 | -1.40 | -1.80 | -28.6% | Miss |
| 12 Nov 2021 16:00 | -2.00 | -1.60 | +20.0% | Beat |
| 12 Aug 2021 16:00 | -2.00 | -2.80 | -40.0% | Miss |
| 14 May 2021 16:00 | -2.00 | -1.60 | +20.0% | Beat |
| 13 Nov 2020 16:00 | -4.00 | -4.20 | -5.0% | Miss |
| 13 Aug 2020 15:00 | -4.00 | -4.00 | 0.0% | In line |
| 14 May 2020 16:00 | -3.60 | -12.72 | -253.3% | Miss |
| 27 Mar 2020 15:00 | -5.00 | -9.60 | -92.0% | Miss |
| 13 Nov 2019 16:00 | -7.80 | -6.20 | +20.5% | Beat |
| 09 Aug 2019 14:00 | -7.40 | -21.00 | -183.8% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 24M | +29.8% | -363K | -1.5% | -0.23 | +92.2% | 359K |
| 2024 | 18.5M | +21.9% | -4.3M | -23.1% | -2.93 | +35.0% | 216K |
| 2023 | 15.2M | +61.5% | -5.9M | -38.5% | -4.51 | +58.0% | -3.7M |
| 2022 | 9.4M | — | -12.2M | -129.7% | -10.73 | — | -8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 24.57 | 24.80 | 22.15 | 23.25 | -6.25% | 22,900 | |
| 11 Nov 2026 | 23.20 | 25.34 | 22.76 | 24.80 | +4.86% | 28,900 | |
| 10 Nov 2026 | 22.14 | 23.90 | 21.79 | 23.65 | +6.53% | 17,700 | |
| 09 Nov 2026 | 19.00 | 22.95 | 19.00 | 22.20 | +19.23% | 47,700 | |
| 06 Nov 2026 | 18.99 | 19.80 | 18.50 | 18.62 | +0.16% | 13,900 | |
| 05 Nov 2026 | 18.71 | 20.24 | 18.48 | 18.59 | -5.01% | 18,000 | |
| 04 Nov 2026 | 18.93 | 19.95 | 18.90 | 19.57 | +5.10% | 8,100 | |
| 03 Nov 2026 | 18.35 | 19.26 | 18.00 | 18.62 | +4.67% | 18,000 | |
| 02 Nov 2026 | 18.48 | 18.70 | 17.79 | 17.79 | -1.71% | 12,800 | |
| 30 Oct 2026 | 19.83 | 19.83 | 17.99 | 18.10 | -6.46% | 25,900 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Precipio Announces Q3-2026 Financial Results (opens in a new tab) InvestorsHub · 11 Nov 2026 18:21
- Precipio, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 11 Nov 2026 13:30
- Precipio (PRPO) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 11 Nov 2026 10:28
- Precipio, Inc. (PRPO) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 23:30
- Precipio Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 18:04
- Precipio Q3 EPS $0.00, Sales $7.331M Up From $6.767M YoY (opens in a new tab) Benzinga · 10 Nov 2026 17:32
- Precipio Announces Q3-2026 Shareholder Update Call (opens in a new tab) InvestorsHub · 29 Oct 2026 17:54
- PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? (opens in a new tab) Zacks · 22 Sep 2026 18:16
- The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and Precipio (opens in a new tab) Zacks · 11 Sep 2026 10:20
- PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? (opens in a new tab) Zacks · 24 Aug 2026 17:37
- Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong (opens in a new tab) Zacks · 21 Aug 2026 16:31
- Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ... (opens in a new tab) GuruFocus.com · 21 Aug 2026 04:02
- Precipio, Inc. Q2 2026 Earnings Call Summary (opens in a new tab) Moby · 15 Aug 2026 13:30
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 24.80 USD
- Market cap
- 41.7M
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 10.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.8 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 3.5 / 10 No figures for this part: it counts as a cautious 35%. | — |
- Thin interest cover: operating profit is only -16.5× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 85% of the figures (grade B). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 59.62× | Weak | 14.16× |
| Price / book | 2.8× | Fair | 3.5× |
| Price / sales | 1.5× | Good | 3.33× |
| EV / EBITDA | -746.46× | Weak | 11.19× |
| Free cash flow yield | 3.1% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 44.6% | Good | 54.9% |
| Operating margin | -5.3% | Weak | 5.8% |
| Net margin | -4.1% | Weak | 1.2% |
| Return on equity | -8% | Weak | 4.4% |
| Return on assets | -4.3% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 36.7% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.25× | Good | 0.4× |
| Interest cover | -16.47× | Weak | 2.17× |
| Current ratio | 1.77× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow PRPO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.